Microbion Overview

  • Year Founded
  • 2000

Year Founded

  • Status
  • Private

  • Employees
  • 15

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $11.9M

  • Investors
  • 10

Microbion General Information

Description

Operator of a pharmaceutical company intended to develop a novel class of compounds for the treatment of resistant and difficult-to-treat infections. The company's therapeutics develop bismuth-thiols to prevent microbial biofilms from forming on medical devices implanted in the body, enabling doctors to help patients suffering from infections, including chronic infections and antibiotic-resistant infections.

Contact Information

Website
www.microbioncorp.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 5 West Mendenhall Street
  • Suite 202
  • Bozeman, MT 59715
  • United States
+1 (406)
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Vertical(s)
Life Sciences
Corporate Office
  • 5 West Mendenhall Street
  • Suite 202
  • Bozeman, MT 59715
  • United States
+1 (406)

Microbion Timeline

2021202220232024
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Microbion Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
13. Later Stage VC 27-Jul-2021 $11.9M Completed Clinical Trials - Phase 2
12. Grant 22-Feb-2021 Completed Clinical Trials - Phase 2
11. Grant 28-May-2020 Completed Clinical Trials - Phase 1
10. Later Stage VC (Series A) 05-Jan-2017 Completed Clinical Trials - Phase 1
9. Later Stage VC 22-Jan-2016 Completed Clinical Trials - Phase 1
8. Grant 16-Jul-2014 Completed Clinical Trials - Phase 1
7. Seed Round 03-Apr-2013 Completed Clinical Trials - Phase 1
6. Grant 31-Oct-2012 Completed Clinical Trials - Phase 1
5. Angel (individual) 15-Sep-2011 $933K $2.38M Completed Clinical Trials - Phase 1
4. Angel (individual) 05-Nov-2009 $414K $1.44M Completed Clinical Trials - Phase 1
To view Microbion’s complete valuation and funding history, request access »

Microbion Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a pharmaceutical company intended to develop a novel class of compounds for the treatment of resistant and d
Drug Discovery
Bozeman, MT
15 As of 2022

South San Francisco, CA
 

Cambridge, MA
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Microbion Competitors (22)

One of Microbion’s 22 competitors is Genentech, a Formerly VC-backed company based in South San Francisco, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Genentech Formerly VC-backed South San Francisco, CA
AnTolRx Venture Capital-Backed Cambridge, MA
Mission Therapeutics Venture Capital-Backed Cambridge, United Kingdom
Oncorus Formerly VC-backed Andover, MA
Immunitas Therapeutics Venture Capital-Backed Waltham, MA
You’re viewing 5 of 22 competitors. Get the full list »

Microbion Patents

  • 84

    Total Documents Applications and Grants

  • Total Patents Families

  • 50

    Granted

  • 19

    Pending

  • Expiring in next 12 mo

Microbion Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2023204833-A1 Methods for treating nontuberculous mycobacteria diseases Pending 10-Jan-2022
EP-4463148-A1 Methods for treating nontuberculous mycobacteria diseases Pending 10-Jan-2022
US-20240285571-A1 Methods of treating bone infections Pending 01-Oct-2020
US-20230124862-A1 Bismuth thiol compounds and compositions and methods of treating microbial co-infections Pending 24-Mar-2020
AU-2019312592-A1 Bismuth-thiol compositions and methods for treating wounds Pending 31-Jul-2018 A61K31/29
To view Microbion’s complete patent history, request access »

Microbion Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Microbion Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds
5N Plus Corporation Minority
Impact Assets Impact Investing Minority
CARB-X University
Cystic Fibrosis Foundation Limited Partner
GF Securities Investment Bank Minority
You’re viewing 5 of 10 investors. Get the full list »

Ready to get started?

Request a free trial

Microbion FAQs

  • When was Microbion founded?

    Microbion was founded in 2000.

  • Where is Microbion headquartered?

    Microbion is headquartered in Bozeman, MT.

  • What is the size of Microbion?

    Microbion has 15 total employees.

  • What industry is Microbion in?

    Microbion’s primary industry is Drug Discovery.

  • Is Microbion a private or public company?

    Microbion is a Private company.

  • What is Microbion’s current revenue?

    The current revenue for Microbion is .

  • How much funding has Microbion raised over time?

    Microbion has raised $46.4M.

  • Who are Microbion’s investors?

    5N Plus, Impact Assets, CARB-X, Cystic Fibrosis Foundation, and GF Securities are 5 of 10 investors who have invested in Microbion.

  • Who are Microbion’s competitors?

    Genentech, AnTolRx, Mission Therapeutics, Oncorus, and Immunitas Therapeutics are some of the 22 competitors of Microbion.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »